Monia Brett P, Chief Operating Officer, sold 34,000 shares of the Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) in an exchange that happened on November 23rd, 2018. The stock was sold at an average price of $55.00 per share, amounting to a transaction worth $1,870,058. The sale was made public in a document filed with the SEC. Additionally, SVP, Antisense Research BENNETT C FRANK sold 12,500 shares of this stock in a transaction that took place on November 1st, 2018. The stock was sold at an average price of $49.54 per share, for a total exchange amounting to $619,245. After the transaction, the SVP, Antisense Research BENNETT C FRANK currently holds 19,396 shares of the company’s stock, which is worth approximately $1086176.
With this stock price’s latest movement, it is now -6.37% away from its 1-year high and 43.33% higher than its 1-year low price. In the past seven days, the stock price volatility for Ionis Pharmaceuticals, Inc. was 4.16%, whereas its volatility in the past 30 days has been 4.45%. This public company’s stock also has a beta score of 2.35. When the beta value is less/more than 1, it can imply that the stock is less/more volatile than the wider stock market – a metric that traders will surely be keeping tabs on.
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) most recently published its quarterly earnings results. The firm posted -$0.03 earnings per share (EPS) for the three-month period, surpassing analysts’ consensus estimate of -$0.16 by $0.13. The publicly-traded organization reported revenue of $145.40 million for the quarter, compared to the average analyst forecast calling for $152.68 million, which was missing the analyst consensus estimate.
Shares of Ionis Pharmaceuticals, Inc. (IONS) plunged -5.95%, amounting to a loss of -$3.54 per share, to finish the regular trading session at $56.00 on Tuesday 12/04/2018. After beginning the session at $59.4, shares of Ionis Pharmaceuticals, Inc. reached as high as $59.75 during the day, while hitting a 1-day low of $55.82. Trade volume reached 1,454,021 shares against this stock’s average daily volume of 1.09M shares, with a total float of 124.96M. As a consequence of the price decrease, Ionis Pharmaceuticals, Inc. now has a current market value of 7.59B.
Invitation Homes Inc. (NYSE:INVH) subtracted -1.26% to its trading price by the close of the most recent session, dropping from its previous closing price of $21.51 to $21.24. This stock increased in value by -0.09% during the last 7-day period, and experienced a loss of 0.05% over the past 30-day period. In the past three months, this stock’s price lost by -8.61% , and subtracted -2.84% to its price during the last six months of trading. INVH demonstrated a yearly price loss of -9.50% , while its year-to-date (YTD) price performance has been down -9.89% . This stock’s price changed by +3.56% compared to its 90-day low, and moved down -11.28% comparing to its 90-day high price.
Have a quick look on short, medium and long-term indicators. According to the Composite Indicator, Trendspotter rated the INVH stock as “Sell”. In the short-term, Invitation Homes Inc. (INVH) has a 20-day average volume of 1,869,690 shares and short-term indicators sets the INVH stock as “ 20% Sell ” on average basis. In the medium-term, INVH stock has a 50-Day average volume of 1,973,908 shares and medium-term indicators gave the average rating of “ 25% Sell ”, while in the long-term period the FB stock has a 100-Day average volume of 2,125,420 shares. On average, long-term indicators rated the stock as “67% Sell ”. The overall picture from all short, medium and long-term indicators sets the INVH stock as “40% Sell ” on average basis.
Recently, multiple brokerages have sent out reports on INVH. Mizuho, for example, Downgrade its rating on shares of Invitation Homes Inc. from “Buy ” to a “ Neutral”according to a research note from Wednesday November 14th, 2018. while giving the stock a “Outperform” rating, as stated in a research report from Thursday, March 29th, 2018. B. Riley FBR, Inc., on the other hand, Resumed a “Buy” rating on this stock, while posting a $26 price target on shares of this company’s stock in a research note dated Monday, March 12th, 2018.
In other news related to Invitation Homes Inc. stock, 77.59% shares of INVH held by institutions. The total number of institutions who held the INVH shares was 169, according to most recent SEC filling. During the past quarter, total 62,580,781 shares held by institutions with the net change of 4,961,833 shares. In the meantime, 22 new institutions bought the shares of Invitation Homes Inc. for the first time and 21 institutions sold all their holdings in the company’s common stock. 86 institutions increased their investment in the INVH stock and 57 institutions decreased their investment in the Invitation Homes Inc. (INVH)’s stock during the last quarter.